All-In Summit: In conversation with Brian Armstrong

Armstrong said the settlement path would have required Coinbase to delist every asset except Bitcoin, a condition he viewed as existential. Rather than accept it, Coinbase chose litigation, despite advisers telling him a public company should settle rather than fight the SEC.

Armstrong’s preferred crypto regime is tougher on centralized custodians and lighter on decentralized software. He backed audits, AML/KYC and registration for centralized firms, while treating self-custody and non-custodial protocols more like software and proposing a sandbox for startups facing enormous legal costs.

Coinbase’s internal technical target for Base is simple: every transaction under one cent and confirmed within one second. Armstrong said Base already improved cost and speed by roughly an order of magnitude, but believes that threshold is needed before new crypto applications can become truly mass-market.

Armstrong said Coinbase had surpassed 100 million global sign-ups and roughly half of active customers were already doing something besides trading. He cited spending via Coinbase Card, staking, dapps and payments, framing utility—not speculation—as the company’s next growth problem.

Despite its legal fights, Armstrong said he deliberately limits them to about 5% of Coinbase’s resources and keeps 95% focused on product. His concern is that regulatory conflict can consume the company until it becomes “some lawsuit” instead of a builder.

Coinbase was expanding internationally without abandoning the U.S., but India illustrated how fragile that plan could be. Armstrong said the company had launched in Canada and opened an International Exchange, while its India launch was shut down after only three days and slated for another attempt.

Armstrong had met Sam Bankman-Fried and thought he was smart but reckless; he did not detect the fraud. What troubled him was FTX’s apparent liquidity: he knew Coinbase’s own budget and repeatedly wondered where Bankman-Fried was finding the money to write such large checks.

Outside Coinbase, Armstrong was putting his own capital into scientific infrastructure and longevity rather than simply more crypto. He described ResearchHub as an attempt to make research operate more like open-source software, and NewLimit as an epigenetic-programming effort aimed at longevity.